Shares of Huntington Bancshares (NASDAQ: HBAN ) have been on a tear of late. Since the beginning of last year, they're up nearly 37%, outperforming the S&P 500 by roughly eight percentage points and ascending recently to a new 52-week high. As I write, they're trading for the highest price since the financial crisis took its toll on the bank. For current or prospective investors in Huntington, in turn, this performance begs the question: What's left for its shares going forward?
HBAN data by YCharts.
While it's impossible to predict the future, what can be said is that Huntington's valuation leaves room for further gains. Trading at 1.25 times its tangible book value, the bank is by no means cheap -- a common saying in the industry is to "buy at half of book value and sell at two times book value." At the same time, it's far from expensive. Take U.S. Bancorp, the nation's largest regional bank, as a counterpoint. Its shares trade for 2.54 times tangible book value. Or even BB&T, a regional bank operating primarily throughout the mid-Atlantic region. It changes hands at 1.86 times tangible book.
Top Performing Stocks To Watch Right Now: ABM Industries Incorporated (ABM)
ABM Industries Incorporated provides integrated facility solutions services in the United States and internationally. It offers floor cleaning and finishing, window washing, furniture polishing, carpet cleaning and dusting, and other building cleaning services for commercial office and industrial buildings, retail stores, shopping centers, warehouses, airport terminals, health facilities, educational institutions, stadiums and arenas, and government buildings. The company also provides mobile and onsite services comprising mechanical engineering and technical services and solutions for infrastructure systems, including maintenance, retro-commissioning, mechanical retrofits and upgrades, electric vehicle charging stations, electrical service, systems start-ups, performance testing, and energy audits to government facilities, military installations, commercial infrastructure, airports/transportation centers, healthcare centers and hospitals, data centers, manufacturing facil ities, educational campuses, corporate office buildings, resorts, shopping malls, museums, and residences. In addition, it offers support programs to government, such as leadership development, education and training, language support, medical support, and construction management services; and food and facility solutions services to hospitals, healthcare systems, long-term care facilities, and retirement communities. Further, the company operates parking lots and garages at office buildings, hotels, medical centers, retail centers, sports and entertainment arenas, educational institutions, municipalities, and airports; and provides transportation services. Additionally, it offers security services comprising staffing of security officers, mobile patrol services, investigative services, electronic monitoring of fire, life safety systems, access control devices, and security consulting services to various facilities. The company was founded in 1909 and is headquartered in New York, New York.
Advisors' Opinion:- [By Dan Caplinger]
Next Monday, ABM Industries (NYSE: ABM ) will release its latest quarterly results. With the stock having recently hit 52-week highs, can the company keep delivering the growth that investors want to see?
- [By Dividends4Life]
ABM Industries Incorporated (ABM) offers floor cleaning and finishing, window washing, furniture polishing, carpet cleaning and dusting, and other building cleaning services. December 9th the company increased its quarterly dividend 3.3% to $0.155 per share. The dividend is payable February 3, 2014, to stockholders of record on January 2, 2014. The yield based on the new payout is 2.3%.
Top Regional Bank Stocks To Watch For 2014: Momenta Pharmaceuticals Inc.(MNTA)
Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the characterization and process engineering of complex molecules. These complex molecules include proteins; polypeptides; and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company applies its technology for the development and commercialization of generic versions of complex drug products, as well as for the discovery and development of novel drugs. It offers Enoxaparin sodium injection, a generic version of Lovenox to prevent and treat deep vein thrombosis, and to support the treatment of acute coronary syndromes. The company?s products also include M356, an abbreviated new drug application under FDA review, is a generic version of Copaxone for the reduction of the frequency of relapses in patients with relapse-remitting multiple sclerosis; M118, which completed a Phase IIa clinical trial as an anticoagulant for acute coronary syndromes; and M402, a novel HSPG-based product candidate that is in preclinical development as a potential anti-cancer agent. It has collaboration agreements with Sandoz AG and Sandoz Inc. to develop and commercialize Enoxaparin sodium injection. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By James Brumley]
Just bear in mind this is largely an all-or-nothing bet on the drug, though PRAN stock could rally nicely leading up to its D-Day approval.
Momenta Pharmaceuticals (MNTA)Like Sagent Pharmaceuticals, Momenta Pharmaceuticals (MNTA) is a generic drugmaker. And also like Sagent, priced at $16.14 per share, MNTA stock is easily put into the cheap stocks category.
- [By Dan Caplinger]
Lately, the stock market has turned on every word from the Federal Reserve, and so this morning's comments from Federal Reserve Chairwoman Janet Yellen received a huge amount of attention from investors Monday. With Yellen offering a much more encouraging assessment of how long interest rates might remain low in order to stimulate and sustain economic growth, stocks climbed sharply, with the Dow posting triple-digit gains. Yet for MannKind (NASDAQ: MNKD ) , Momenta Pharmaceuticals (NASDAQ: MNTA ) , and Idera Pharmaceuticals (NASDAQ: IDRA ) , the news today was far from good, as all three stocks suffered declines of 10% or more.
- [By Maxx Chatsko]
Shares of biotech innovator Momenta Pharmaceuticals (NASDAQ: MNTA ) entered into a nosedive in early June, but quickly recovered after analysts at UBS AG upgraded the stock from "neutral" to "buy." I don't put any faith in analyst projections -- and neither should you -- but I do see value in the company's technology. Momenta has developed a platform for analyzing and characterizing complex molecules that could significantly reduce R&D costs and development times of drugs in the pipeline. If you're an investor looking for a biotech company with boatloads of potential, you may be wondering about adding Momenta to your portfolio. Fool contributor Maxx Chatsko breaks down that decision for investors in the following video.
Top Regional Bank Stocks To Watch For 2014: OmniVision Technologies Inc.(OVTI)
OmniVision Technologies, Inc. designs, develops, and markets semiconductor image-sensor devices. The company offers CameraChip image sensors, which are single-chip solutions that integrate various functions, such as image capture, image processing, color processing, signal conversion, and output of a processed image or video stream for use in various consumer and commercial mass-market applications; and CameraCube imaging devices that are image sensors with integrated wafer-level optics. It also provides companion chips used to connect its image sensors to various interfaces, including the universal serial bus and other industry standard interfaces; and companion digital signal processors that perform compression in standardized still photo and digital video formats. In addition, the company designs and develops software drivers for Linux, Mac OS, and Microsoft Windows, as well as for embedded operating systems, such as Blackberry OS, Palm OS, Symbian, Windows CE, Windows Embedded, and Windows Mobile. Its products are used in mobile phones, notebooks, Webcams, digital still and video cameras, commercial and security and surveillance, and automotive and medical applications, as well as in entertainment devices. The company sells its products directly to original equipment manufacturers and value added resellers, as well as indirectly through distributors worldwide. OmniVision Technologies, Inc. was founded in 1995 and is based in Santa Clara, California.
Advisors' Opinion:- [By Evan Niu, CFA]
Once upon a time, I was also an OmniVision (NASDAQ: OVTI ) bull, thinking the image sensor specialist's lead in backside-illuminated technology gave it a substantial leg up against the competition. When OmniVision lost the iPhone 4S primary camera spot to Sony,�that was just the first sign that things may never be the same. The company subsequently lost the iPhone 5 primary sensor, also to Sony. HTC has gone with STMicroelectronics�for the "UltraPixel" sensor in its One flagship (OmniVision sources the secondary sensor), which lends to the idea that BSI sensors are becoming commoditized. Goodbye, pricing power. I gave up on OmniVision long ago.
Top Regional Bank Stocks To Watch For 2014: KCG Holdings Inc (KCG)
KCG Holdings, Inc., incorporated on December 26, 2012, is an independent securities firm. The Company offers investors a range of services designed to address trading needs across asset classes, product types and time zones. It has three operating segments: Market Making, Global Execution Services, and Corporate and Other. On July 1, 2013, the Company announced the completion of the merger whereby Knight Capital Group, Inc. (Knight) and GETCO Holding Company, LLC (GETCO) were combined as part of KCG Holdings, Inc., a new holding company.
Market Making
The Company�� Market Making segment principally consists of market making in global equities and listed domestic options. As a market maker, the Company commits capital for trade executions by offering to buy securities from, or sell securities to, institutions and broker-dealers. The Market Making segment primarily includes client, and to a lesser extent, non-client market making activities in which the Company operates as a market maker in equity securities quoted and traded on the Nasdaq Stock Market; the over-the-counter (OTC) market for New York Stock Exchange (NYSE), NYSE Amex Equities (NYSE Amex), NYSE Arca listed securities, and several European exchanges. As a complement to electronic market making, the Company�� cash trading business handles specialized orders and also transacts on the OTC Bulletin Board, marketplaces operated by the OTC Markets Group Inc. and the Alternative Investment Market (AIM) of the London Stock Exchange. The segment also provides trade executions as an equities Designated Market Maker (DMM) on the NYSE and NYSE Amex. The Market Making segment also includes the Company�� option market making business which trades on all domestic electronic exchanges.
Global Execution Services
The Company�� Global Execution Services segment offers access through its electronic agency-based platforms to markets and self-directed trading in equities, options, fixed income, foreign ! exchange and futures. The Global Execution Services segment generally does not act as a principal to transactions that are executed within this segment however, it will commit capital on behalf of clients, as needed, and generally earns commissions for acting as agent between the principals to the trade. Global Execution Services includes equity sales and trading (including exchange traded funds (ETFs)), reverse mortgage origination and securitization and asset management. This segment also facilitates client orders through program, block, and riskless principal trades and provides capital markets services, including equity offerings, as well as private placements. The Global Execution Services segment also includes the futures commission merchant (FCM) business, which consists of certain assets and liabilities that the Company acquired or assumed from the futures division of Penson Financial Services, Inc.
Corporate and Other
The Corporate and Other segment invests in strategic financial services-oriented opportunities, allocates, deploys and monitors all capital, and maintains corporate overhead expenses and all other income and expenses that are not attributable to the other segments. The Corporate and Other segment houses functions that support the Company�� other segments, such as self-clearing services, including stock lending activities.
The Company competes with BGC Partners (BGCP), Chicago Board Options Exchange (CBOE), CME (CME), GFI Group Inc. (GFIG), ICE (ICE), ITG (ITG), Forex Capital Markets (FXCM), MarketAxess (MKTX), National Association of Securities Dealers Automated Quotations (NASDAQ), and NYSE.
Advisors' Opinion:- [By Sam Mamudi]
Knight, which in July joined with Getco LLC to form KCG Holdings Inc. (KCG) after losing more than $460 million because of the error, agreed to settle charges stemming from mistakes made on Aug. 1, 2012, according to a statement today from the U.S. Securities and Exchange Commission. The regulator said Knight violated the SEC�� market access rule, instituted in 2010 to prevent these kinds of trading missteps.
No comments:
Post a Comment